| Execution period | 12 months |
|---|
BSE filing, NSE: DRAGARWQ. Summary written from the filing by ALFA Finder's alert engine.
Dr. Agarwal's Eye Hospital Ltd: key numbers
- Share price
- ₹5,112.20
- Market cap
- ₹2,403 Cr
- Revenue (annual)
- ₹470.9 Cr
- Net profit (annual)
- ₹70.10 Cr
- P/E (TTM)
- 31.5×Sector 52.0×
- Promoter holding
- 72.67%+0.00% QoQ
- FII holding
- 2.22%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Dr. Agarwal's Eye Hospital Ltd
All →Dr. Agarwal's Eye Hospital Acquisition Worth ₹711.2 Cr
Dr. Agarwal's Eye Hospital Limited has completed its amalgamation with Dr. Agarwal's Health Care Limited, with the transaction valued at ₹711.21 Crore.
- Value
- ₹711.2 Cr
Dr. Agarwal's Eye Hospital Acquisition
Dr. Agarwal's Eye Hospital announced the effectiveness of its Scheme of Amalgamation starting November 01, 2026, and fixed a record date for share allotment.
Dr. Agarwal's Eye Hospital Other Announcement
The company submitted its quarterly shareholding pattern as mandated by SEBI. The filing provides a breakdown of shareholdings among promoters and the public.
Dr. Agarwal's Eye Hospital Acquisition
The NCLT Chennai Bench has sanctioned the Scheme of Amalgamation between Dr. Agarwal’s Eye Hospital Limited and Dr. Agarwal’s Health Care Limited. The company awaits the order copy.
Dr. Agarwal's Eye Hospital Annual General Meeting
Dr. Agarwal's Eye Hospital Limited held its 32nd Annual General Meeting on September 09, 2026. The meeting concluded with the approval of six business resolutions.
Dr. Agarwal's Eye Hospital Business Update
Dr. Agarwals Eye Hospital inaugurated its new Pinhole Pupilloplasty Centre in Chennai. This facility provides advanced specialized clinical treatments for patients with complex corneal conditions.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.